Search

Your search keyword '"Kessens I"' showing total 3 results
Start Over Author "Kessens I"
3 results on '"Kessens I"'

1. Versorgungsqualität der Psoriasis in Europa – Ergebnisse der Studie PsoBarrier EU in vier Ländern

Author

Langenbruch, A, Mohr, N, Kessens, I, Czarnecka-Operacz, M, Puig, L, Dauden, E, Iversen, L, and Augustin, M

Subjects
ddc: 610, Medicine and health
Abstract

Hintergrund: Nachdem zwei nationale Studien aus den Jahren 2005 und 2007 auf Defizite in der Psoriasis-Versorgung hingewiesen hatten, hat sich die Versorgungsqualität für Patient*innen mit Psoriasis in Deutschland maßgeblich verbessert. Dennoch bestehen weiterhin Versorgungsdefizite, [zum vollständigen Text gelangen Sie über die oben angegebene URL]

Published
2021
Full Text
View/download PDF

2. Shared Decision Making bei der Behandlung von Psoriasis – Ergebnisse der 'PsoBarrier EU'-Studie in vier europäischen Ländern

Author

Langenbruch, A, Mohr, N, Kessens, I, Czarnecka-Operacz, M, Puig, L, Dauden, E, Iversen, L, and Augustin, M

Subjects
ddc: 610, Medicine and health
Abstract

Hintergrund: Ziel der “PsoBarrier EU”-Studie ist es, in vier europäischen Ländern Barrieren für eine leitlinienbasierte Psoriasis-Versorgung zu identifizieren. Ein Thema ist auch das Ausmaß der Beteiligung von Patient*innen an Therapieentscheidungen. Laut einer [zum vollständigen Text gelangen Sie über die oben angegebene URL]

Published
2021
Full Text
View/download PDF

3. PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries.

Author

Langenbruch A, Mohr N, Andrees V, Kessens I, Reich A, Czarnecka-Operacz M, Puig L, Dauden E, Iversen L, and Augustin M

Subjects
Humans, Cross-Sectional Studies, Europe, Poland, Quality of Life, Psoriasis diagnosis, Psoriasis epidemiology, Psoriasis therapy
Abstract

Enhanced treatment options for psoriasis and growing use of guidelines increased the potential to better quality of psoriasis care in Europe. The aim of the PsoBarrier EU study is to compare the quality and processes of psoriasis care in four European countries with different healthcare systems, based on validated quality indicators. This cross-sectional survey was conducted in dermatology centres in Denmark, Germany, Poland and Spain on 1,304 patients, using standardized patient and physician questionnaires. Measured by quality of psoriasis care indicators, patients in Poland had the most critical outcomes, such as the highest disease severity (Psoriasis Area and Severity Index; PASI) and lowest health-related quality of life (Dermatology Life Quality Index; DLQI). This indicates differences in psoriasis care, with Polish participants experiencing more severe psoriasis and its consequences. Differences in the healthcare systems, which create barriers to accessing treatments, could explain variations in quality of care.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results